Portfoliotracker

PureTech Health plc

PRTC.L · LSE · Healthcare Biotechnology 35/100 D

117,54 GBP
▼ −0,66 (−0,56 %)
Trading delayed by 15 min
Price as of 17. 11. 12:35, fetched 17. 11. 12:54
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score35 / 100 Market cap288 mil. GBP P/E– Forward P/E-4,9 P/S45,2 P/B1,0 EV/EBITDA-2,7 Dividend yield– FCF yield– EPS0,00 GBP Net margin33,2 % Return on equity0,4 % Beta0,75 Debt / equity0,59
52-week range 106,60 to 143,60
3-month average volume0,7 M

We do not have financial statements yet

The company reports in USD, while the price is quoted in GBP. We do not convert statements between currencies yet, because the multiples (P/E, P/S and others) would come out wrong, so we do not show them here. You can see the price and its history above.

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development and oral therapies based on defined bacterial consortia that is in phase 3 clinical stage. PureTech Health plc was incorporated in 2015 and is based in Boston, Massachusetts.

Employees
90
Country
United States
Data since
19. 6. 2015

Explore further

Similar companies IPO.LGNS.LCTEC.LOXB.LKNOS.L

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account